Septal Glucagon-Like Peptide 1 Receptor Expression Determines Suppression of Cocaine-Induced Behavior
Once you reach your therapeutic dose, the expected rate of weight loss is 0.5-1% of your body weight per week
Although these results hint at potential beyond-weight reproductive benefits (83), the extremely small sample size ( n = 28), open-label design, and lack of objective measurements for key biological intermediates (e.g., oocyte/embryo quality and endometrial receptivity), combined with controversies over the adequacy of the washout period, mean these conclusions should be viewed as exploratory rather than definitive
For information on managing common GLP-1 side effects, see our guides on semaglutide nausea and tirzepatide dosage adjustment
But while GLP-1s are commonly used by perimenopausal women, this population has been largely ignored in studies of the drugs' risks and benefits
Get In Touch CNBC Newsletters Sign up for free newsletters and get more CNBC delivered to your inbox Sign Up Now Get this delivered to your inbox, and more info about our products and services
